IM Cannabis Said It Is Evaluating Certain Strategic Opportunities To Expand Its Operations Into The United States Cannabis Market Following President Trump's Executive Order

The initiative follows President Donald Trump's executive order signed on December 18, 2025, which directs the Attorney General to expedite the rescheduling of marijuana from Schedule I to Schedule III under the Controlled Substances Act, recognizing its medical benefits while maintaining federal oversight.